학술논문
From evidence to clinical practice: Bridging the gap of new liver cancer therapies in Latin America.
Document Type
article
Source
Annals of Hepatology, Vol 29, Iss 3, Pp 101185- (2024)
Subject
Language
English
ISSN
1665-2681
Abstract
The most common primary liver tumors are hepatocellular carcinoma and cholangiocarcinoma. They constitute the sixth most common neoplasia and the third cause of cancer-related deaths worldwide. Although both tumors may share etiologic factors, diagnosis, prognostic factors, and treatments, they differ substantially in determining distinctive clinical management. In recent years, significant advances have been made in the management of these neoplasms, particularly in advanced stages. In this review, we focus on the most relevant diagnostic, prognostic, and treatment aspects of both, hepatocellular carcinoma and cholangiocarcinoma, underlying their applicability in Latin America.